tiprankstipranks
TipRanksTop Financial ExpertsInsidersFrank Karbe

Frank Karbe Insider Profile

11 Followers
Frank Karbe, Director at Phathom Pharmaceuticals, holds 91.62K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Cidara Therapeutics (Ticker: CDTX), holds 526.52K shares in Better Therapeutics (Ticker: BTTX).
See the Hottest Stocks Based on Insider Trading >
tipranks
Frank Karbe

Frank Karbe
Phathom Pharmaceuticals (PHAT)
Director

Ranked #23,058 out of 108,921 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+11.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$7M
87.28%
12.35%
0.37%
0.00%
A breakdown of Frank Karbe's holdings
See the Top Stocks by Insiders

Insider Roles

Exelixis
(EXEL)
EVP & CFO
Phathom Pharmaceuticals
(PHAT)
Director
Arbutus Biopharma
(ABUS)
Director
Better Therapeutics
(BTTX)
CEO, Director
Roles that Frank Karbe holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Phathom Pharmaceuticals
(PHAT)
Rating:Informative Buy
Date:Dec 16, 2024 - Dec 16, 2025
Return:+87.20%
The most profitable trade made by Frank Karbe
See the Latest Stocks Traded by Insiders

Frank Karbe's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PHAT
Phathom Pharmaceuticals
May 21, 2026
Director
Uninformative Buy
―
$864.00K
BTTX
Better Therapeutics
Dec 20, 2023
CEO, Director
Uninformative Buy
―
―
CDTX
Cidara Therapeutics
Jan 07, 2026
―
Uninformative Sell
1.67M
$0.00
ABUS
Arbutus Biopharma
Dec 31, 2014
Director
Uninformative Buy
―
$25.90K
MYOV
Myovant Sciences
Jul 09, 2021
―
Informative Sell
70.30K
$5.73M
KDNY
Chinook Therapeutics
―
―
―
―
EXEL
Exelixis
Nov 17, 2011
EVP & CFO
Uninformative Buy
―
$6.10M
List of latest transactions for each holding click on a transaction to see Frank Karbe's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Frank Karbe insider profile FAQ

What is the percentage of profitable transactions made by Frank Karbe?
The percentage of profitable transactions made by Frank Karbe is 67%.
    What is the average return per transaction made by Frank Karbe?
    The average return per transaction made by Frank Karbe is 11.70%.
      What stocks does Frank Karbe hold?
      Frank Karbe holds: PHAT, BTTX, CDTX, ABUS, MYOV, KDNY, EXEL stocks.
        What was Frank Karbe’s latest transaction?
        Frank Karbe latest transaction was an Uninformative Buy of ―.
          What was Frank Karbe's most profitable transaction?
          Frank Karbe’s most profitable transaction was an Informative Buy of PHAT stock on December 16, 2024. The return on the trade was 87.20%.
            What is Frank Karbe's role in Phathom Pharmaceuticals?
            Frank Karbe's role in Phathom Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.